JonathonBrettCohenMD

PubMed

• 1 citations
  A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.
  Walter Hanel, Polina Shindiapina, David A Bond, Yazeed Sawalha, Narendranath Epperla, Timothy Voorhees, Rina Li Welkie, Ying Huang, Gregory K Behbehani, Xiaoli Zhang, ...> ;Cancers. 2023 Feb 24
• Postibrutinib relapse outcomes for patients with marginal zone lymphoma.
  Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K Moyo, Nishitha Reddy, Julia Sheets, David M Weiner, Praveen Ramakrishnan Geethakumar...> ;Blood Advances. 2023 Jan 10
• 1 citations
  Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.
  Andres Chang, Akil Akhtar, Lilin Lai, Victor M Orellana-Noia, Susanne L Linderman, Ashley A McCook-Veal, Jeffrey M Switchenko, Manpreet Saini, Rajesh M Valanparambil, ...> ;Cancer Research Communications. 2022 Dec 1
• MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN...
  Jonathon B Cohen, Nirav N Shah, Alvaro J Alencar, James N Gerson, Manish R Patel, Bita Fakhri, Wojciech Jurczak, Xuan Ni Tan, Katharine L Lewis, Timothy Fenske, Cather...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Oct 1
• EXABS-205-MCL Immunotherapeutic Options for Patients with MCL Who Progress on BTK Inhibitors.
  Jonathon B Cohen> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Oct 1
• Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial.
  Jason T Romancik, Zhengjia Chen, Pamela B Allen, Edmund K Waller, Kelly Valla, Amanda Colbert, Cecilia Rosand, Alexandra F Palmer, Christopher R Flowers, Jonathon B Cohen> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Dec 1
• Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis.
  Danny Luan, Tolulope Fatola, Ahmed Toure, Christopher R Flowers, Brian Link, Jonathan W Friedberg, Jonathon B Cohen, Brad Kahl, Izidore S Lossos, Loretta Nastoupil, Ma...> ;Blood Advances. 2022 Aug 9
• A multicenter, real-world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus.
  Christopher Dittus, Natalie Grover, Tarsheen Sethi, Jonathon B Cohen, Alfredo Voloschin, Janhvi Rabadey, Xianming Tan, Anne Beaven, Steven I Park> ;Ejhaem. 2022 Aug 1
• 1 citations
  SOHO State of the Art Updates and Next Questions: Managing Relapsed Mantle Cell Lymphoma.
  Jason T Romancik, Drew G Gerber, Tony Zhuang, Jonathon B Cohen> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Aug 1
• Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia.
  Andres Chang, Anton M Sholukh, Andreas Wieland, David L Jaye, Mary Carrington, Meei-Li Huang, Hong Xie, Keith R Jerome, Pavitra Roychoudhury, Alexander L Greninger, Je...> ;The Journal of Clinical Investigation. 2022 Sep 15
• Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
  Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K Moyo, Nishitha Reddy, Julia Sheets, David M Weiner, Praveen Ramakrishnan Geethakumar...> ;Journal of Hematology & Oncology. 2022 Jul 16
• A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma.
  David A Bond, Ying Huang, Beth A Christian, Samantha Jaglowski, Don Benson, Lapo Alinari, Robert A Baiocchi, Jonathon B Cohen, Kristie A Blum, Kami J Maddocks> ;Leukemia & Lymphoma. 2022 Jul 1
• 3 citations
  Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Coh...
  Peter Martin, Jonathon B Cohen, Michael Wang, Anita Kumar, Brian Hill, Diego Villa, Jeffrey M Switchenko, Brad Kahl, Kami Maddocks, Natalie S Grover, Keqin Qi, Lori Pa...> ;Journal of Clinical Oncology. 2023 Jan 20
• 9 citations
  Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.
  Andres Chang, Akil Akhtar, Susanne L Linderman, Lilin Lai, Victor M Orellana-Noia, Rajesh Valanparambil, Hasan Ahmed, Veronika I Zarnitsyna, Ashley A McCook-Veal, Jeff...> ;Journal of Clinical Oncology. 2022 Sep 10
• 6 citations
  Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentr...
  Carla Casulo, Melissa C Larson, Julianne J Lunde, Thomas M Habermann, Izidore S Lossos, Yucai Wang, Loretta J Nastoupil, Christopher Strouse, Dai Chihara, Peter Martin...> ;The Lancet. Haematology. 2022 Apr 1
• 1 citations
  Sequencing of Novel Therapies for Mantle Cell Lymphoma.
  Jason T. Romancik, Jonathon B. Cohen> ;Current Treatment Options in Oncology. 2021 Nov 23
• 3 citations
  Dose Finding Study of Ibrutinib and Venetoclax in Relapsed or Refractory Mantle Cell Lymphoma.
  Craig A. Portell, Nolan A. Wages, Brad S. Kahl, Lihua E. Budde, Robert W. Chen, Jonathon B. Cohen, Nikole Varhegyi, Gina R. Petroni, Michael E. Williams> ;Blood Advances. 2021 Oct 26
• 3 citations
  Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
  Alessia Castellino, Yucai Wang, Melissa C. Larson, Matthew J. Maurer, Brian K. Link, Umar Farooq, Andrew L. Feldman, Sergei Syrbu, Thomas M. Habermann, Jonas Paludo, D...> ;Blood Advances. 2021 Oct 18
• 2 citations
  Diagnostic retinal biopsy in the management of secondary non-CNS vitreoretinal lymphoma masquerading as viral retinitis: a case report.
  Aditya Rali, Lucy T Xu, Caroline Craven, Jonathon B. Cohen, Steven Yeh, Hans E. Grossniklaus, Ghazala D O'Keefe> ;International Journal of Retina and Vitreous. 2021 Oct 11
• 2 citations
  Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation
  Peter A. Riedell, Mehdi Hamadani, Kwang Woo Ahn, Carlos Litovich, Claudio G. Brunstein, Amanda F. Cashen, Jonathon B. Cohen, Narendranath Epperla, Brian T. Hill, Annie...> ;British Journal of Haematology. 2021 Sep 28
• 24 citations
  Autologous Transplant versus Chimeric Antigen Receptor T-cell Therapy for Relapsed DLBCL in Partial Remission.
  Mazyar Shadman, Marcelo C. Pasquini, Kwang Woo Ahn, Yue Chen, Cameron J. Turtle, Peiman Hematti, Jonathon B. Cohen, Farhad Khimani, Siddhartha Ganguly, Reid W. Merryma...> ;Blood. 2021 Sep 27
• 19 citations
  Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
  Victor M. Orellana-Noia, Daniel R Reed, A. Mccook, Jeremy M Sen, Christian M Barlow, Mary-Kate Malecek, Marcus P Watkins, Brad S. Kahl, Michael A. Spinner, Ranjana H. ...> ;Blood. 2021 Sep 27
• 8 citations
  Early Relapse Identifies MCL patients with Inferior Survival after Intensive or Less Intensive Frontline Therapy.
  David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski, Alina S. Gerrie, Subir Goyal, Krithika Shanmugasundaram, Oscar Calzada, Bha...> ;Blood Advances. 2021 Sep 13
• 5 citations
  American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Trans...
  Pashna N. Munshi, Mehdi Hamadani, Ambuj Kumar, Peter Dreger, Jonathan W. Friedberg, Martin Dreyling, Brad S. Kahl, Mats Jerkeman, Mohamed A. Kharfan-Dabaja, Frederick ...> ;Transplantation and Cellular Therapy. 2021 Sep 1
• 6 citations
  Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma
  Victor M. Orellana-Noia, Krista Isaac, Mary-Kate Malecek, Nancy L. Bartlett, Timothy J Voorhees, Natalie S Grover, Steven R. Hwang, N. Nora Bennani, Rachel Hu, Brian T...> ;Blood Advances. 2021 Sep 28
• Join now to see all

Journal Articles

• Intrathecal Central Nervous System Prophylaxis in Patients with Diffuse Large B-cell Lymphoma at an Academic Healthcare System  
  Jonathon Cohen, MD, Clinical Lymphoma, Myeloma, & Leukemia

Abstracts/Posters

• Indolent Lymphoma and Vitamin D (ILyAD): A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Supplemental Effect of Vitamin D on Event-Free Survival i...
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Multi-Institution Phase I/Ib Continual Re-Assessment Study to Identify the Optimal Dose of of Ibrutinib (IBR) and Venetoclax (VEN) in Relapsed or Refractory Mantle Cel...
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Impact of Novel Agents on Outcomes of Patients with Classical Hodgkin Lymphoma and Primary Treatment Failure
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine + Rituximab without Autologous Transplant
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin Lymphoma
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO Database
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Preliminary Clinical Results from a Phase 1 Study of ACTR707 in Combination with Rituximab in Subjects with Relapsed or Refractory CD20+ non-Hodgkin Lymphoma
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Short Time to Treatment Is Associated with Inferior Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Novel Comorbidity Score Derived from a Large Multicenter Retrospective Cohort Study of Patients Treated ...
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin Lymphoma
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Multi-Center Dose-Finding Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Fimepinostat (CUDC-907) in Combination with Venetoclax i...
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)
  Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Expert Perspectives on the Role of BTK Inhibitors in CLL 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• A Phase I/II Study of Ibrutinib and Ixazomib in Relapsed/Refractory Mantle Cell Lymphoma: PrE0404 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Axicabtagene Ciloleucel in the Real World: Outcomes and Predictors of Response, Resistance and Toxicity 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Aggressive Lymphomas 
  60th American Society of Hematology Annual Meeting - 12/1/2018
• Aggressive Lymphomas 
  60th American Society of Hematology Annual Meeting - 12/1/2018
• Join now to see all